USANA not selling
This article was originally published in The Tan Sheet
Executive Summary
Unity Acquisition Corp.'s tender offer of $28 per share of USANA Health Science's stock is "inadequate and not in the best interests of USANA's shareholders," the Salt Lake City-based firm announces July 3. USANA says the special committee of its board of directors "unanimously" determined the firm should reject Unity Acquisition's offer. This is not the first tender offer USANA has received. In May, Gull Holdings offered to acquire USANA's outstanding shares for $26 per share (1"The Tan Sheet" May 26, 2008, In Brief)...
You may also be interested in...
USANA for sale
USANA Health Sciences' board formed a special committee of independent directors to evaluate a tender offer expected from Gull Holdings, Ltd. and others, to acquire all of its outstanding shares at $26 per share, USANA says May 20. Gull Holdings indicated its intent in a May 13 notice to the Securities and Exchange Commission...
'Touchless Plants' To Virtually Trained Workforces - Indian Cos Share Digitalization Tips
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
More IVD Mergers: Agilent Buys Resolution, Hologic Acquires Diagenode
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: